Suchergebnisse - "EC 3.2.2.6"

PubPharm (1.621)

1

CD38-Specific Gallium-68 Labeled Peptide Radiotracer Enables Pharmacodynamic Monitoring in Multiple Myeloma with PET

enthalten in: Advanced science (Weinheim, Baden-Wurttemberg, Germany) | 2024

von Sharma, A. | Gupta, K. | Mishra, A. | +9

UpdateOf: bioRxiv. 2023 Oct 31;:. - PMID 37214794

2

CD38 promotes hematopoietic stem cell dormancy

enthalten in: PLoS biology | 2024

von Ibneeva, L. | Singh, S. | Sinha, A. | +17

3

Zeta-associated protein 70 expression in chronic lymphocytic leukemia : Relevance in Indian context

enthalten in: Indian journal of pathology & microbiology | 2023

von Gupta, R. | Garg, N. | Singh, A. | +1

4

Efficacy of venetoclax plus anti-CD38 monoclonal antibody-containing therapies among t(11;14) positive multiple myeloma patients regardless of timing of prior treatment with this antibody

enthalten in: European journal of haematology | 2023

von Regidor, B. | Siddiqi, D. | Beatty, B. | +6

5

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research

enthalten in: Cells | 2023

von Kitada, M. | Araki, S. | Koya, D.

6

Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease

enthalten in: International journal of medical sciences | 2023

von Dong, M. | Wang, S. | Pei, Z.

7

Outcomes of anti-CD38 isatuximab plus pomalidomide and dexamethasone in five relapsed myeloma patients with prior exposure to anti-C38 daratumumab : case series

enthalten in: Hematology (Amsterdam, Netherlands) | 2022

von Djebbari, F. | Poynton, M. | Sangha, G. | +6

8

Innate-like bystander-activated CD38+ HLA-DR+ CD8+ T cells play a pathogenic role in patients with chronic hepatitis C

enthalten in: Hepatology (Baltimore, Md.) | 2022

von Huang, C. | Fan, J. | Jeng, W. | +10

9

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells

enthalten in: The Journal of experimental medicine | 2022

von Camponeschi, A. | Kläsener, K. | Sundell, T. | +15

10

A Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma

enthalten in: American journal of clinical pathology | 2022

von Alsuwaidan, A. | Koduru, P. | Fuda, F. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[163]